Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Prime Medicine, Inc. (PRME) Institutional Ownership & Insider Trading

187 institutions reported holding Prime Medicine, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PRMEPrime Medicine, Inc.Follow PRME — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
665.7M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
30 Oct, in 6 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

187 institutions held 58.8% of the shares. Across filers that reported both quarters, shares held changed +8.4%.

Increased+57New+20Decreased-63Closed-19

Largest moves, shares (millions)

Goldman Sachs Group+2.5MARK Investment Management+2.1MCitadel Advisors+1.7MD. E. Shaw-0.7MRenaissance Technologies-0.6MAmova Asset Management…-0.5M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.4Sep 24-3.7Dec 24-3.6Mar 25-1.8Jun 25+33.7Sep 25+5.6Dec 25+2.7Mar 26+8.2Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26187107+8.4%57206319
Mar 2618998+3.0%66294424
Dec 2518098+6.2%59413926
Sep 2516292+57.4%6047296
Jun 2512059-3.0%35293228
Mar 2512260-5.7%38173226
Dec 2413064-5.4%36263015
Sep 2411669-0.7%37133217

Prime Medicine, Inc. — questions

Who owns Prime Medicine, Inc. stock?
187 institutions reported Prime Medicine, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Alphabet Inc. (9.1%), BlackRock, Inc. (5.3%), ARK Investment Management LLC (4.6%).

Every figure on this page comes from Prime Medicine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.